barr 882 (Hydroxyurea 500 mg)
Pill with imprint barr 882 is Pink & Purple, Capsule-shape and has been identified as Hydroxyurea 500 mg. It is supplied by Teva Pharmaceuticals USA.
Hydroxyurea is used in the treatment of chronic myelogenous leukemia; anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Hydroxyurea 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for barr 882




Hydroxyurea
- Imprint
- barr 882
- Strength
- 500 mg
- Color
- Pink & Purple
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
citric acid anhydrous,
benzyl alcohol,
ferrosoferric oxide,
butylparaben,
D&C Red No. 28,
D&C Yellow No. 10,
sodium phosphate dibasic,
edetate calcium disodium,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
gelatin,
lactose monohydrate,
magnesium stearate,
methylparaben,
shellac,
propylparaben sodium,
propylene glycol,
ferric oxide red,
sodium lauryl sulfate,
sodium propionate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00555-0882 | Barr Laboratories, Inc. |
42291-0321 | AvKare, Inc. |
54868-4773 (Discontinued) | Physicians Total Care Inc. (repackager) |
54569-5715 | A-S Medication Solutions, LLC (repackager) |
Related images for "barr 882"
More about hydroxyurea
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (32)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: antimetabolites
Patient resources
- Drug Information
- Hydroxyurea Tablets
- Hydroxyurea Capsules 200 mg, 300 mg, 400 mg
- Hydroxyurea Capsules 500 mg
Other brands
Hydrea, Droxia, Siklos, Mylocel
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.